Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (551-560 of 974) with videos related to

Pageof 98
Sort By:
Immunogenetics|March 1, 2015
Erratum to: IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based testJean-François Gélinas, Thomas Fabre, Philippe Willems, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 24, 2025
Dynamic Changes in Bilirubin Predict 90-Day Mortality in Patients With Hepatocellular Carcinoma and Acute Decompensations of Cirrhosis: The HCC-AD ScoreOliver Moore, Fran Neveu-Coble, Scott Read, et al.
ESC Heart Failure|October 27, 2021
Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survivalSara Shimoni, Meital Zikri, Dan Haberman, et al.
Nature Reviews. Gastroenterology & Hepatology|November 29, 2018
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisKonstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen, et al.
Journal of Gastroenterology and Hepatology|September 14, 2021
All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapyIan Lockart, Behzad Hajarizadeh, Niamh Buckley, et al.
International Journal of Molecular Sciences|November 11, 2022
Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis PatientsValeri Cuciuc, Sagi Tshori, Livi Grib, et al.
Annals of the Rheumatic Diseases|May 27, 2019
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosisAdi Mor, Michal Segal Salto, Avi Katav, et al.
Journal of Hepatology|May 13, 2019
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, AustraliaMaryam Alavi, Matthew G Law, Heather Valerio, et al.
The American Journal of Cardiology|March 5, 2011
Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failureGideon Charach, Itamar Grosskopf, Arie Roth, et al.
World Journal of Cardiology|December 17, 2010
Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcomeShmuel Schwartzenberg, Arnon Afek, Gideon Charach, et al.
Pageof 98

Showing results (551-560 of 974) with videos related to

Sort By:
Pageof 98
Immunogenetics|March 1, 2015
Erratum to: IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based testJean-François Gélinas, Thomas Fabre, Philippe Willems, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 24, 2025
Dynamic Changes in Bilirubin Predict 90-Day Mortality in Patients With Hepatocellular Carcinoma and Acute Decompensations of Cirrhosis: The HCC-AD ScoreOliver Moore, Fran Neveu-Coble, Scott Read, et al.
ESC Heart Failure|October 27, 2021
Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survivalSara Shimoni, Meital Zikri, Dan Haberman, et al.
Nature Reviews. Gastroenterology & Hepatology|November 29, 2018
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisKonstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen, et al.
Journal of Gastroenterology and Hepatology|September 14, 2021
All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapyIan Lockart, Behzad Hajarizadeh, Niamh Buckley, et al.
International Journal of Molecular Sciences|November 11, 2022
Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis PatientsValeri Cuciuc, Sagi Tshori, Livi Grib, et al.
Annals of the Rheumatic Diseases|May 27, 2019
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosisAdi Mor, Michal Segal Salto, Avi Katav, et al.
Journal of Hepatology|May 13, 2019
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, AustraliaMaryam Alavi, Matthew G Law, Heather Valerio, et al.
The American Journal of Cardiology|March 5, 2011
Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failureGideon Charach, Itamar Grosskopf, Arie Roth, et al.
World Journal of Cardiology|December 17, 2010
Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcomeShmuel Schwartzenberg, Arnon Afek, Gideon Charach, et al.
Pageof 98